Ted W. Love

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Amy Kim by Power of Attorney for Ted W. Love
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ted W. Love:

Form 4 holding Director

Royalty Pharma plc

Security class
Class A Ordinary Shares
Shares / value
46,234
Estimated value
$1,397,575
Report date
07 Jun 2024
Price
$30.23
Ownership
Direct
Form 4 holding Director

Structure Therapeutics Inc.

Security class
Share Option (right to buy)
Shares / value
51,804
Estimated value
Report date
23 Jun 2025
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

GILEAD SCIENCES, INC.

Security class
Non-qualified Stock Option (Right to Buy)
Shares / value
12,648
Estimated value
Report date
08 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

GILEAD SCIENCES, INC.

Security class
Non-qualified Stock Option (Right to Buy)
Shares / value
4,884
Estimated value
Report date
30 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director

Global Blood Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
05 Oct 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director

Global Blood Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
05 Oct 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Seagen Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
14 Dec 2023
Price
$229.00
Ownership
Direct
Form 4 holding Director

Seagen Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
14 Dec 2023
Price
$229.00
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding Director

Seagen Inc.

Security class
Stock Options (Right to Buy)
Shares / value
0
Estimated value
Report date
14 Dec 2023
Price
Ownership
Direct
Underlying class
Common stock
Underlying amount

Insider Reports Filed by Ted W. Love

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .